PHEBURANE
Live / Registered — Registered — Section 71 accepted (as of 11 Aug 2023)
What this means for you
Registered since 29 Jan 2013. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79117600
- Registration number
- 4281315
- Mark type
- Stylized text
- Filed
- 05 Jun 2012
- Published for opposition
- 13 Nov 2012
- Registered
- 29 Jan 2013
- Attorney of record
- Terrence J. McAllister
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations intended to treat rare diseases, namely, urea cycle disorders [, organic acidurias, spinal muscular atrophy, Huntington's disease, tuberculosis, amyotrophic lateral sclerosis, lymphoma, leukemia, maple syrup urine disease, thalassemia, sickle cell disease cystic fibrosis, alpha-1 antitrypsine deficiency ]
Owner
- MPerium B.V., NL
- LUCANE PHARMA, PARIS, FR
- LUCANE PHARMA, FR
- LUCANE PHARMA, FR
Prosecution history
- 07 Aug 2025 — CHANGE OF OWNER RECEIVED FROM IB
- 27 May 2024 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 18 Apr 2024 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 18 Apr 2024 — INVALIDATION PROCESSED
- 11 Apr 2024 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 11 Aug 2023 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 11 Aug 2023 — REGISTERED-SEC.71 ACCEPTED
- 11 Aug 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 Jan 2023 — TEAS SECTION 71 RECEIVED
- 16 Jul 2022 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 15 Jul 2022 — INTERNATIONAL REGISTRATION RENEWED
- 29 Jan 2022 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 12 Jun 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 29 Nov 2018 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 29 Nov 2018 — REGISTERED-SEC.71 ACCEPTED